CN111212613A - Intraocular lens (IOL) injector and method of use - Google Patents
Intraocular lens (IOL) injector and method of use Download PDFInfo
- Publication number
- CN111212613A CN111212613A CN201780095064.6A CN201780095064A CN111212613A CN 111212613 A CN111212613 A CN 111212613A CN 201780095064 A CN201780095064 A CN 201780095064A CN 111212613 A CN111212613 A CN 111212613A
- Authority
- CN
- China
- Prior art keywords
- iol
- injector
- cartridge
- lumen
- sleeve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000007246 mechanism Effects 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 abstract description 14
- 239000000463 material Substances 0.000 description 15
- 230000003287 optical effect Effects 0.000 description 9
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 208000002177 Cataract Diseases 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- -1 but not limited to Polymers 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 150000001993 dienes Chemical class 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229920005669 high impact polystyrene Polymers 0.000 description 2
- 239000004797 high-impact polystyrene Substances 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- NJVOHKFLBKQLIZ-UHFFFAOYSA-N (2-ethenylphenyl) prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1C=C NJVOHKFLBKQLIZ-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000013037 co-molding Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1662—Instruments for inserting intraocular lenses into the eye
- A61F2/1678—Instruments for inserting intraocular lenses into the eye with a separate cartridge or other lens setting part for storage of a lens, e.g. preloadable for shipping
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1662—Instruments for inserting intraocular lenses into the eye
- A61F2/1667—Instruments for inserting intraocular lenses into the eye with rotatable plungers
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
The present invention provides an apparatus and method for inserting an IOL into a patient's eye. The IOL injector is configured to automatically load the IOL into the injector by folding and aligning the IOL into the lens cartridge of the injector without requiring the surgeon to manually manipulate the IOL during surgery. The injector device is configured to properly orient and align the IOL within the injector device and to maintain proper alignment throughout delivery of the IOL to the eye of a patient, thereby ensuring that the IOL is properly positioned and oriented in a predetermined location in the eye.
Description
Background
Technical Field
The present invention relates generally to ophthalmic surgical devices and methods, and more particularly to devices and methods for inserting an intraocular lens (IOL) into a patient's eye.
Background
Intraocular lens (IOL) injectors are devices designed to insert IOLs into a patient's eye. Such lenses are surgical implants designed to augment or replace the natural lens of the eye and are used to treat certain eye diseases. For example, cataract-induced vision impairment is often treated by surgical removal and replacement of the lens of the eye. In this procedure, a small 1-4mm incision is made in the patient's eye. The surgeon then uses a tool to insert the eye through the incision, emulsify (disintegrate) and remove the natural lens of the eye. Once removed, an intraocular lens is inserted into the eye.
To insert the lens without enlarging the incision, a compressible or foldable lens is used and is typically inserted through the incision using an injector device. The IOL is designed to return to its deployed shape within the eye in a predetermined orientation upon entry into the eye. In this procedure, the placement of the IOL is critical, particularly for toric lenses used to treat astigmatism, which require precise positioning and orientation at a predetermined location in the eye. Incorrect placement requires the surgeon to manually manipulate the positioning of the IOL, which can result in damage to the eye and damage to the IOL.
IOLs are typically shipped and stored in a relaxed state to avoid damaging the lens. Thus, conventional injector devices require the surgeon to load the IOL into the injector device, thereby requiring the surgeon to exercise a great deal of skill in loading the IOL in the correct orientation while avoiding damage to the IOL. Conventional injector devices do not allow the surgeon to control the orientation of the lens during loading and/or delivery of the lens to the eye. Accordingly, there is a need for an improved IOL injector that is easier to use while ensuring proper delivery of the IOL to the eye.
Disclosure of Invention
The present invention addresses the deficiencies of conventional injectors by providing an IOL injector that is optionally preloaded with an IOL in an unfolded state, wherein the injector is configured to automatically fold and properly align the IOL during delivery of the IOL without relying on the skill of the surgeon.
Accordingly, in one aspect, the present invention provides an IOL injector. The syringe comprises a syringe body elongated along a longitudinal axis and provided with a lumen. The lens cartridge is operably connected to the injector body and includes an inner cavity configured to receive the IOL and a positioning mechanism for folding and aligning the IOL within the lens cartridge inner cavity. An injector tip is operably connected with the lens cartridge, the injector tip having a lumen terminating in a distal opening. A plunger having an elongate shaft is slidably disposed in the interior cavity of the syringe body. The plunger is configured to contact a folded IOL loaded in the lens cartridge lumen and push the IOL along the longitudinal axis through the injector tip lumen and out the distal opening when the plunger is pressed into the deployed position. The injector further comprises a sleeve operably connected to the lens cartridge. The lens cartridge is configured to mechanically fold an IOL preloaded in the lens cartridge and align the IOL within the lens cartridge interior cavity via the positioning mechanism upon moving the sleeve from a distal first position in which the sleeve is over the injector tip to a proximal second position in which the sleeve is over the lens cartridge.
In an embodiment, the positioning mechanism comprises a first cartridge portion and a second cartridge portion that are mechanically moved towards each other perpendicular to the longitudinal axis of the device to fold the IOL as the sleeve is moved over the lens cartridge from a distal first position above the injector tip.
In another aspect, the present invention provides a method of implanting an IOL using the injector device of the present invention. The method comprises the following steps: providing an IOL injector having an IOL preloaded in a lens cartridge; translating the sleeve from a distal first position over the injector tip to a proximal second position over the lens cartridge, thereby folding and aligning the IOL within the lens cartridge lumen; and the plunger is depressed to transition it from the undeployed position to the deployed position to push the folded IOL along the longitudinal axis of the device and eject the IOL from the distal opening of the injector tip lumen into the patient's eye.
In yet another aspect of the invention, the invention provides a tool for practicing the method of the invention. The kit comprises an IOL injector of the invention and an IOL optionally preloaded in the injector. In an embodiment, the injector device is preloaded with the IOL such that the sleeve is in the first distal position and the IOL is in a deployed state within the lens cartridge lumen.
Drawings
The present invention will be more readily understood from the following detailed description of exemplary embodiments taken in conjunction with the following drawings.
FIG. 1 is a perspective view of an IOL injector device according to one embodiment of the invention with sleeve 60 in a first position covering injector tip 40;
FIG. 2 is an anterior view of the IOL injector depicted in FIG. 1 in one embodiment of the invention;
FIG. 3 is a rear view of the IOL injector depicted in FIG. 1 in one embodiment of the invention;
FIG. 4 is a left side view of the IOL injector depicted in FIG. 1 in one embodiment of the invention;
FIG. 5 is a right side view of the IOL injector depicted in FIG. 1 in one embodiment of the invention;
FIG. 6 is a top view of the IOL injector depicted in FIG. 1 in one embodiment of the invention;
FIG. 7 is a bottom view of the IOL injector depicted in FIG. 1 in one embodiment of the invention;
FIG. 8 is a perspective view of an IOL injector device according to one embodiment of the invention with sleeve 60 in a second position covering lens cartridge 30;
FIG. 9 is an anterior view of the IOL injector depicted in FIG. 8 in one embodiment of the invention;
FIG. 10 is a rear view of the IOL injector depicted in FIG. 8 in one embodiment of the invention;
FIG. 11 is a left side view of the IOL injector depicted in FIG. 8 in one embodiment of the invention;
FIG. 12 is a right side view of the IOL injector depicted in FIG. 8 in one embodiment of the invention;
FIG. 13 is a top view of the IOL injector depicted in FIG. 8 in one embodiment of the invention;
FIG. 14 is a bottom view of the IOL injector depicted in FIG. 8 in one embodiment of the invention;
FIG. 15 is an exploded view of an IOL injector according to one embodiment of the invention;
FIG. 16 is an enlarged perspective view of the first cartridge portion 34 depicted in FIG. 15 in one embodiment of the invention;
FIG. 17 is an enlarged perspective view of the second cartridge portion 36 depicted in FIG. 15 in one embodiment of the invention;
FIG. 18 is an enlarged top perspective view of the injector body 20 and lens cartridge 30 depicted in FIG. 15 in one embodiment of the present invention;
FIG. 19 is an enlarged bottom perspective view of the injector body 20 and lens cartridge 30 depicted in FIG. 15 in one embodiment of the present invention;
FIG. 20 is an enlarged perspective view of the sleeve 60 depicted in FIG. 15 in one embodiment of the present invention;
FIG. 21 is a front view of the syringe tip 40 depicted in FIG. 15 in one embodiment of the present invention;
figure 22 is an enlarged top view of the distal region of the IOL injector depicted in figure 1 in one embodiment of the invention.
Detailed Description
The present invention is described in preferred embodiments in the following description with reference to the figures, in which like numbers represent the same or similar elements. Reference throughout this specification to "one embodiment," "an embodiment," or similar language means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, appearances of the phrases "in one embodiment," "in an embodiment," and similar language throughout this specification may, but do not necessarily, all refer to the same embodiment.
The described features, structures, or characteristics of the invention may be combined in any suitable manner in one or more embodiments. In the following description, numerous specific details are set forth in order to provide a thorough understanding of embodiments of the invention. One skilled in the relevant art will recognize, however, that the invention may be practiced without one or more of the specific details, or with other methods, components, materials, and so forth. In other instances, well-known structures, materials, or operations are not shown or described in detail to avoid obscuring aspects of the invention.
In various aspects, the present invention provides an apparatus and method for inserting an IOL into a patient's eye. The IOL injector is configured to automatically load the IOL into the injector by folding and aligning the IOL into the lens cartridge of the injector without requiring the surgeon to manually manipulate the IOL during surgery. The injector device is configured to properly orient and align the IOL within the injector device and to maintain proper alignment throughout delivery of the IOL to the eye of a patient, thereby ensuring that the IOL is properly positioned and oriented in a predetermined location in the eye.
Referring to fig. 1-14, one such IOL injector 10 includes an injector body 20, a lens cartridge 30 operatively connected to the injector body, an injector tip 40 operatively connected to the lens cartridge, a plunger 50, and a sleeve 60 operatively connected to the lens cartridge.
Figure 15 is an exploded view showing the operative association of the components of the IOL injector. As shown, plunger 50, injector body 20, lens cartridge 30, injector tip 40 and sleeve 60 are disposed along the longitudinal axis of the IOL injector with the plunger disposed at the proximal end of the injector and injector tip 40 disposed at the distal end of the injector. In an embodiment, the lumen traverses the entire length of the device such that an IOL loaded into lens cartridge lumen 32 can be pushed by distal tip 56 of elongate shaft 52 of plunger 50 along the longitudinal axis through injector tip lumen 42 and out distal opening 44 into the patient's eye as plunger 50 is advanced distally from the undeployed position to the deployed position.
As discussed herein, the injector is configured to mechanically fold and align the IOL within the lens cartridge such that proper orientation is achieved when the IOL is loaded into the lens cartridge lumen and delivered to the eye. Folding and alignment of the IOL in the lens cartridge lumen is accomplished by a positioning mechanism disposed in the lens cartridge 30 that is operatively connected to the sleeve 60. Transitioning sleeve 60 from a first position, as shown in fig. 1-7, in which sleeve 60 covers injector tip 40, to a second position, as shown in fig. 8-14, in which sleeve 60 covers lens cartridge 30, causes the positioning mechanism to fold the IOL from the first unfolded state to the second folded state and align the IOL within lens cartridge lumen 32. Once the IOL is folded and properly aligned within lens cartridge lumen 32, the IOL can be delivered to the patient's eye by distally advancing plunger 50 from the undeployed position to the deployed position.
In an embodiment, the positioning mechanism may comprise one or more components operatively associated to fold the IOL and interact with the sleeve 60. Fig. 15 shows an embodiment of a syringe comprising a positioning mechanism having a first cartridge portion 34 and a second cartridge portion 36. The first and second cartridge portions 34 and 36 are shown in fig. 16 and 17, respectively. In this embodiment, the first cartridge portion 34 has a surface adapted to contact the inner surface of the sleeve and push the first cartridge portion towards the second cartridge portion 36 when the sleeve 60 is moved from the first position to the second position. As shown in fig. 16, surface 38 is configured to contact an inner surface of sleeve 60 when the sleeve is moved from the first position to the second position. In the embodiment shown in fig. 16, surface 38 has a distal tapered region 39 that facilitates contact with the inner surface of sleeve 60 as it is moved over lens cartridge 30.
As indicated by the arrows in fig. 22, sleeve 60 moves from a first position (as shown in fig. 22) toward lens cartridge 30 to a second position in which sleeve 60 covers the first and second cartridge portions (34 and 36) moving first cartridge portion 34 inwardly toward second cartridge portion 36 perpendicular to the longitudinal axis of the device. Movement of the first cartridge portion 34 causes opposing surfaces ( surfaces 31 and 33 shown in figures 16 and 17, respectively) provided on the first and second cartridge portions to fold the IOL such that the IOL is folded in half along the longitudinal axis of the injector device. Thus, in the folded state, the IOL is substantially folded in half along its major dimension (i.e., length). In embodiments, where the IOL includes haptics, the injector is configured to position the one or more haptics at the correct orientation over the IOL's optical area for delivery. In one embodiment, a properly aligned IOL has anterior haptics that push against the optic and posterior haptics that contact the distal tip 56 of the plunger 50. Thus, a properly oriented IOL "marks" the haptics to the optic area. Those skilled in the art will recognize that it is advantageous to construct distal tip 56 from a material that will not damage the IOL upon contact. In embodiments, the distal tip 56 comprises a polymeric material, such as silicone or other elastically deformable polymer.
In an embodiment, to facilitate alignment of sleeve 60 with lens cartridge 30, one or more raised ridge surfaces may be provided on the inner surface of the sleeve. For example, fig. 20 depicts an embodiment in which the inner surface of the sleeve contains a plurality of ridges 65 for interacting with corresponding grooves provided on lens cartridge 30. An embodiment of lens cartridge 30 having grooves 70 for receiving ridges disposed on the inner surface of the sleeve is shown in fig. 19.
In certain aspects, the IOL injector is provided in the form of a tool with an IOL, optionally preloaded in the lens cartridge of the injector. This reduces the manual handling required by the surgeon while performing the surgical procedure, thereby reducing the risk of contamination and damage to the IOL that may occur during handling of the IOL. Advantageously, placing the injector device in a preloaded state allows the injector device to be sterilized at the factory at the same time as the IOL during packaging. In the pre-loaded injector embodiment, the lens injector is provided with the IOL pre-loaded in the lens cartridge (where the lens is in the deployed state), the sleeve is in the first position covering the injector tip, and the plunger is in the undeployed state. In use, the surgeon need only open the injector package, transfer the sleeve from the first position to the second position to fold and align the IOL in the lens cartridge, and deliver the IOL to the patient's eye by transferring the plunger from the undeployed position to the deployed position. In addition, the IOL injector device may be configured for a single use whereby the injector device is discarded after the IOL is delivered to the eye.
Accordingly, in one aspect, the present invention provides a method of implanting an IOL in an eye of a patient. The method comprises the following steps: providing an IOL injector of the present invention having an IOL preloaded in a lens cartridge; translating the sleeve from a distal first position over the injector tip to a proximal second position over the lens cartridge, thereby folding and aligning the IOL within the lens cartridge lumen; and the plunger is depressed to transition it from the undeployed position to the deployed position to push the folded IOL along the longitudinal axis of the device and eject the IOL from the distal opening of the injector tip lumen into the patient's eye.
In an embodiment, the syringe may be configured to lock the sleeve in the second position. For example, the syringe may include a locking mechanism that prevents movement of the sleeve from the second position to the first position. Those skilled in the art will appreciate that this may be accomplished in a variety of ways, for example, the locking mechanism may comprise a snap lock, wherein the sleeve comprises one or more locking structures that snap into corresponding grooves provided on the lens cartridge.
It will be appreciated that the lumen extending along the longitudinal axis of the syringe need not have a constant diameter. In an embodiment, the lumen has a different diameter at different regions of the syringe. For example, the lens cartridge lumen may have a different diameter than the injector tip lumen. In one embodiment, the diameter of the lens cartridge lumen is greater than the diameter of the injector tip lumen. Further, in embodiments, the syringe tip lumen tapers from a larger diameter at a proximal end of the syringe tip to a smaller diameter at a distal end of the syringe tip where the distal opening is located.
In embodiments, the cross-sectional area of the syringe tip lumen decreases from a larger diameter at the proximal end of the syringe tip to a smaller diameter at the distal end of the syringe tip where the distal opening is located. Additionally, the cross-sectional shape of the syringe tip lumen may be different at the distal end of the syringe tip lumen as compared to the proximal end of the syringe tip lumen.
Fig. 21 is a front view of the syringe tip 40, showing an embodiment in which the distal opening 44 has an elongated circular cross-sectional shape. It should be understood that the cross-sectional shape of the distal opening may be any shape necessary to maintain the proper folding and orientation of the IOL for delivery to the eye. This may depend in part on the type and shape of IOL being delivered. For example, the cross-sectional shape of the distal opening may be square, circular, elliptical, rectangular, triangular, or curvilinear triangular.
The IOL injector may be constructed from a variety of different materials. Those skilled in the art will recognize that different components of the syringe may be constructed of different materials to impart different structural characteristics in different regions of the device. Further, various regions of the delivery lumen may comprise a polymer or lubricious coating.
Some embodiments of the present invention may provide a polyurethane polymer having a polyurethane polymer partially or entirely; styrene related copolymers such as, but not limited to, polyolefins, polyamides, PEBAX, butyl diene styrene Acrylate (ABS), styrene butyl diene styrene (SBS), and/or High Impact Polystyrene (HIPS); a polyester polymer; and their polymer blends or copolymers. Such materials may be sufficiently flexible to enable the creation of small diameter insertion devices, and may also maintain or introduce other beneficial properties.
To ensure that the IOL traverses the delivery lumen without causing damage to the lumen and/or the IOL, the delivery lumen should be able to withstand the forces to which it is subjected during insertion. Thus, the delivery lumen may be formed of a material that is sufficiently flexible to withstand these forces without cracking or rupturing. In addition, to reduce the risk of damage to the IOL, and also reduce the insertion force required to perform insertion, the delivery lumen may be formed of a material that is sufficiently smooth, mixed with a lubricious additive, coated with a lubricious material, or otherwise minimizes the forces that tend to bond the IOL to the inner walls of the lumen. These considerations are particularly applicable to the distal end of the injector tip because the tapering of the delivery lumen increases the normal force experienced by the delivery lumen as the IOL moves distally.
Additionally, to counteract frictional forces that may be experienced during insertion, in some embodiments, a coating made of a hydrophilic polymer material may be applied to the delivery lumen or lens cartridge to provide additional lubricity. For example, in some embodiments, the coating may comprise one or more hydrophilic polymeric materials, such as, but not limited to, hydrophilic polyurethanes, polyvinylpyrrolidones, polyacrylic acids, polyacrylamides, polyhydroxyethylmethacrylate, and/or hyaluronic acid, and the like. It should be noted, however, that the lubricant used in the delivery lumen need not be applied uniformly along the lumen.
Additionally, some embodiments may use materials formed using a co-molding process. Using this process, two or more materials (e.g., polymers) may be extruded and/or injected as a single piece, and may allow for the use of materials having different physical properties. For example, materials having both sufficient toughness and other desired properties may be used. For example, a polyurethane with sufficient toughness may be used, and another polyurethane with the desired lubricating properties may also be used.
In some embodiments, the syringe is constructed using a polymer composition having grafted hydrophilic and lubricating groups as described in U.S. patent application No. 2013/0129953 to Lee, which is incorporated herein by reference. Such compositions utilize polypropylene, polycarbonate, polyamide, cellulose acetate and acrylic polymers or copolymers, which are suitable base polymers for grafting.
The following examples are provided to further illustrate embodiments of the present invention and are not intended to limit the scope of the present invention. While these examples are typical examples that may be used, other processes, methods, or techniques known to those skilled in the art may be used instead.
Example 1
Refractive cataract surgery using an IOL injector with a hydrophobic IOL
Thirty (30) sets of the IOL injector of the present invention were used to deliver thirty (30) hydrophobic folded single-piece intraocular lenses (IOLs) to simulate surgical procedures during refractive cataract surgery. The 30 hydrophobic folded single-piece intraocular lenses consisted of 10 low diopter, 10 medium diopter, 10 high diopter IOLs. All lenses were delivered by the injector of the present invention according to the loading and delivery procedures described in the instructions for use.
The optical properties, sagittal and overall surface and volume uniformity of the IOL, as well as the folded lens opening time were evaluated before and after surgical procedures using the injector of the present invention. The syringe of the present invention was also evaluated for cartridge and tip performance, such as overall cartridge and tip surface and volume uniformity. According to ISO 11979-2 part 2 of the Ophthalmic implant-Intraocular lenses (Ophthalmic implants-Intraocular lenses): optical Properties and test methods (Optical properties and methods) and ISO 11979-3 Ocular implants-Intraocular lenses (ocular implants-Intraocular lenses) part 3: mechanical properties and test methods, IOL optical properties and overall surface and volume uniformity checks were performed.
After delivery, Nikon was usedTMThe SMZ-1 stereomicroscope was used to see if all lenses were likely to be damaged or scratched. All lenses delivered were intact or scratched and met the dimensional specifications. Furthermore, none of the cartridges were damaged after lens delivery. The data resulting from the simulated surgical procedure for injector delivery of hydrophobic intraocular lenses of the present invention show: the injector of the present invention is able to successfully deliver low, medium and even high diopter hydrophobic IOLs without affecting the function of the lens.
Example 2
Refractive cataract surgery using an IOL injector with a hydrophilic IOL
Thirty (30) sets of the injector of the present invention were used to deliver thirty (30) hydrophilic folded single-piece intraocular lenses (IOLs) to simulate surgical procedures during refractive cataract surgery. The 30 hydrophilic folded single-piece intraocular lenses consisted of 10 low diopter, 10 medium diopter, 10 high diopter IOLs. All lenses were delivered by the injector of the present invention according to the loading and delivery procedures described in the instructions for use.
The optical properties, sagittal and overall surface and volume uniformity of the IOL, as well as the folded lens opening time were evaluated before and after surgical procedures using the injector of the present invention. The syringe of the present invention was also evaluated for cartridge and tip performance, such as overall cartridge and tip surface and volume uniformity. According to ISO 11979-2 part 2 of the Ophthalmic implant-Intraocular lenses (Ophthalmic implants-Intraocular lenses): optical Properties and test methods (Optical properties and methods) and ISO 11979-3 Ocular implants-Intraocular lenses (ocular implants-Intraocular lenses) part 3: mechanical properties and test methods, IOL optical properties and overall surface and volume uniformity checks were performed.
After delivery, Nikon was usedTMThe SMZ-1 stereomicroscope was used to see if all lenses were likely to be damaged or scratched. All lenses delivered were intact or scratched and met the dimensional specifications. Furthermore, none of the cartridges were damaged after lens delivery. The data showing the results of the simulated surgical procedure for delivering a hydrophilic intraocular lens by the injector of the present invention show: the injector of the present invention is able to successfully deliver low, medium and even high diopter hydrophilic IOLs without affecting the function of the lens.
Although the present invention has been described with reference to the above examples, it is to be understood that modifications and variations are included within the spirit and scope of the present invention. Accordingly, the invention is not limited except as by the following claims.
Claims (22)
1. An intraocular lens (IOL) injector comprising:
a) a syringe body elongated along a longitudinal axis, the syringe body having an inner cavity disposed along the longitudinal axis;
b) a lens cartridge operably connected to the injector body, the lens cartridge having an inner cavity configured to receive an IOL and a positioning mechanism for folding and aligning the IOL within the lens cartridge inner cavity, wherein the lens cartridge inner cavity is coextensive with the injector body inner cavity;
c) an injector tip operably connected with the lens cartridge, the injector tip having a lumen disposed along the longitudinal axis and terminating in a distal opening, wherein the injector tip lumen is coextensive with the injector body lumen;
d) a plunger having an elongate shaft slidably disposed within the injector body lumen from an undeployed position to a deployed position, wherein the plunger is configured to contact the IOL in the lens cartridge lumen and push the IOL along the longitudinal axis through the injector tip lumen and out of the distal opening when the plunger is transitioned to the deployed position; and
e) a sleeve operably connected to the lens cartridge, wherein the lens cartridge is configured to fold and align the IOL within the lens cartridge cavity via the positioning mechanism upon moving the sleeve on the lens cartridge from a first position to a second position, the sleeve covering at least a portion of the lens cartridge in the second position.
2. The IOL injector of claim 1, wherein said sleeve covers the entire lens cartridge and contacts said injector body in said second position.
3. The IOL injector of claim 1, wherein a surface of the injector tip lumen or the lens cartridge lumen comprises a polymer or a lubricious coating.
4. The IOL injector of claim 3, wherein said lubricious coating is a hydrophilic and lubricious polymer or copolymer matrix.
5. The IOL injector of claim 1, wherein said positioning mechanism comprises a first cartridge portion having a surface adapted to contact an inner surface of said sleeve and to urge said first cartridge portion toward a second cartridge portion when said sleeve is moved from said first position to said second position.
6. The IOL injector of claim 1, wherein the IOL is folded in half along the longitudinal axis when the sleeve is in the second position.
7. The IOL injector of claim 5, wherein said surface of said first cartridge portion has a tapered region.
8. The IOL injector of claim 7, wherein said surface of said tapered region is angled with respect to said longitudinal axis.
9. The IOL injector of claim 5, wherein said second cartridge portion has a recess adapted to receive a raised inner surface of said sleeve.
10. The IOL injector of claim 1, wherein said distal opening of said injector tip lumen is a geometric shape selected from the group consisting of square, circular, oval, rectangular, triangular, curvilinear triangular.
11. The IOL injector of claim 1, wherein a proximal region of said injector tip lumen has an opening, wherein a cross-sectional area of said opening is greater than a cross-sectional area of said distal opening.
12. The IOL injector of claim 1, wherein said plunger further comprises a spring disposed on said elongate shaft.
13. The IOL injector of claim 5, wherein said first cartridge portion and said second cartridge portion form a slot for accessing said lens cartridge lumen at said first location.
14. The IOL injector of claim 13, wherein said slot is configured to receive said IOL when a thickness of said IOL is perpendicular to said longitudinal axis.
15. The IOL injector of claim 1, further comprising a locking mechanism configured to secure the sleeve in the second position.
16. The IOL injector of claim 15, wherein said locking mechanism comprises one or more slots disposed on said lens cartridge or said injector body, said slots configured to receive one or more locking structures disposed on said sleeve.
17. A method of implanting an intraocular lens (IOL), comprising:
a) providing an IOL injector, the injector comprising:
i) a syringe body elongated along a longitudinal axis, the syringe body having an inner cavity disposed along the longitudinal axis;
ii) a lens cartridge operably connected to the injector body, the lens cartridge having an inner cavity configured to receive an IOL and a positioning mechanism for folding and aligning the IOL within the lens cartridge inner cavity, wherein the lens cartridge inner cavity is coextensive with the injector body inner cavity;
iii) an injector tip operably connected with the lens cartridge, the injector tip having a lumen disposed along the longitudinal axis and terminating in a distal opening, wherein the injector tip lumen is coextensive with the injector body lumen;
iv) a plunger having an elongate shaft slidably disposed within the injector body lumen from an undeployed position to a deployed position, wherein the plunger is configured to contact the IOL within the lens cartridge lumen and push the IOL along the longitudinal axis through the injector tip lumen and out of the distal opening when the plunger is transitioned to the deployed position; and
v) a sleeve operably connected to the lens cartridge, wherein the lens cartridge is configured to fold and align the IOL within the lens cartridge cavity by the positioning mechanism upon moving the sleeve on the lens cartridge from a first position to a second position, the sleeve covering at least a portion of the lens cartridge in the second position;
b) inserting an IOL into the lens cartridge lumen when the sleeve is in the first position and the plunger is in the undeployed position;
c) transitioning said sleeve from said first position to said second position thereby folding and aligning said IOL in said lens cartridge lumen; and
d) transitioning the plunger from the undeployed position to the deployed position thereby ejecting the IOL from the distal opening of the injector tip lumen into the patient's eye, the IOL being in a folded state upon exiting the distal opening.
18. The method of claim 17, wherein the positioning mechanism includes a first cartridge portion having a surface adapted to contact an inner surface of the sleeve, and the surface urges the first cartridge portion toward a second cartridge portion when the sleeve is moved from the first position to the second position.
19. The method of claim 18, wherein the second cartridge portion has a recess adapted to receive a raised inner surface of the sleeve.
20. A tool, comprising:
a) the IOL injector of claim 1; and
b)IOL。
21. the tool of claim 20, wherein the IOL comprises an optic and at least one haptic extending from the optic in a curved shape.
22. The tool of claim 20 wherein said injector device is preloaded with said IOL such that said sleeve is in said first position and said IOL is in a deployed state in said lens cartridge lumen.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2017/055339 WO2019070282A1 (en) | 2017-10-05 | 2017-10-05 | Intraocular lens (iol) injector and method of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111212613A true CN111212613A (en) | 2020-05-29 |
CN111212613B CN111212613B (en) | 2023-01-20 |
Family
ID=65995255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780095064.6A Active CN111212613B (en) | 2017-10-05 | 2017-10-05 | Intraocular lens (IOL) injector and method of use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3691570A4 (en) |
JP (1) | JP7121798B2 (en) |
CN (1) | CN111212613B (en) |
WO (1) | WO2019070282A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102023105064B3 (en) * | 2023-03-01 | 2024-05-08 | Carl Zeiss Meditec Ag | Packaging arrangement with an injector for introducing an intraocular lens into the capsular bag of an eye |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090312767A1 (en) * | 2008-06-11 | 2009-12-17 | Pollock David P | Intraocular Lens Injector and Method |
US20100106160A1 (en) * | 2008-10-24 | 2010-04-29 | George Tsai | Intraocular lens injection systems and methods |
US20110295264A1 (en) * | 2010-04-02 | 2011-12-01 | Abbott Medical Optics Inc. | Intraocular Lens Insertion Devices |
US20120130390A1 (en) * | 2009-05-22 | 2012-05-24 | Rayner Intraocular Lenses Limited | Intraocular Lens Cartridge |
US20140066946A1 (en) * | 2012-09-04 | 2014-03-06 | Aaren Scientific, Inc. | Preloaded Intraocular Lens (IOL) System and Method |
US20140135782A1 (en) * | 2012-11-09 | 2014-05-15 | Bausch & Lomb Incorporated | Hingeless Cartridge for Use with an Intraocular Lens Injector Providing Haptic Control |
WO2015075488A1 (en) * | 2013-11-20 | 2015-05-28 | Medicontur Orvostechnikai Kft. | Preloaded injector with rotatable member for storing and injecting hydrophobic intra ocular lenses |
JP2016515466A (en) * | 2013-04-19 | 2016-05-30 | スター サージカル カンパニー | Inserter cartridge with improved lubricity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007436A1 (en) * | 1992-09-30 | 1994-04-14 | Vladimir Feingold | Intraocular lens insertion system |
US7422604B2 (en) * | 2003-08-28 | 2008-09-09 | Bausch & Lomb Incorporated | Preloaded IOL injector |
FR2881043B1 (en) * | 2005-01-21 | 2007-04-27 | Corneal Ind Sa | FLEXIBLE INTRAOCULAR IMPLANT INJECTOR |
US20100256651A1 (en) * | 2009-04-07 | 2010-10-07 | Dharmendra Jani | Intraocular Lens Injector with Hydrophilic Coating |
EP3628341A1 (en) | 2010-10-06 | 2020-04-01 | AST Products, Inc. | Functionalized hydrophilic and lubricious polymeric matrix and methods of using same |
DE102013105185B4 (en) * | 2013-05-21 | 2017-01-05 | Carl Zeiss Meditec Ag | Cassette for receiving an intraocular lens, injector device with a cassette and method for folding an intraocular lens in a cassette |
-
2017
- 2017-10-05 JP JP2020519804A patent/JP7121798B2/en active Active
- 2017-10-05 EP EP17927931.0A patent/EP3691570A4/en active Pending
- 2017-10-05 WO PCT/US2017/055339 patent/WO2019070282A1/en unknown
- 2017-10-05 CN CN201780095064.6A patent/CN111212613B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090312767A1 (en) * | 2008-06-11 | 2009-12-17 | Pollock David P | Intraocular Lens Injector and Method |
US20100106160A1 (en) * | 2008-10-24 | 2010-04-29 | George Tsai | Intraocular lens injection systems and methods |
US20120130390A1 (en) * | 2009-05-22 | 2012-05-24 | Rayner Intraocular Lenses Limited | Intraocular Lens Cartridge |
US20110295264A1 (en) * | 2010-04-02 | 2011-12-01 | Abbott Medical Optics Inc. | Intraocular Lens Insertion Devices |
US20140066946A1 (en) * | 2012-09-04 | 2014-03-06 | Aaren Scientific, Inc. | Preloaded Intraocular Lens (IOL) System and Method |
US20140135782A1 (en) * | 2012-11-09 | 2014-05-15 | Bausch & Lomb Incorporated | Hingeless Cartridge for Use with an Intraocular Lens Injector Providing Haptic Control |
JP2016515466A (en) * | 2013-04-19 | 2016-05-30 | スター サージカル カンパニー | Inserter cartridge with improved lubricity |
WO2015075488A1 (en) * | 2013-11-20 | 2015-05-28 | Medicontur Orvostechnikai Kft. | Preloaded injector with rotatable member for storing and injecting hydrophobic intra ocular lenses |
Also Published As
Publication number | Publication date |
---|---|
JP2021502133A (en) | 2021-01-28 |
EP3691570A4 (en) | 2021-05-05 |
CN111212613B (en) | 2023-01-20 |
JP7121798B2 (en) | 2022-08-18 |
EP3691570A1 (en) | 2020-08-12 |
WO2019070282A8 (en) | 2020-04-23 |
WO2019070282A1 (en) | 2019-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2002803B1 (en) | Lens injector lumen tip for wound assisted delivery | |
EP1513473B1 (en) | Iol insertion apparatus and method for preparatory use of same | |
US7947049B2 (en) | IOL injector | |
US20050149057A1 (en) | IOL inserter plunger and body interface | |
US10426602B2 (en) | Intraocular lens (IOL) injector and method of use thereof | |
EP1481652B1 (en) | Lens delivery system | |
EP1845899B1 (en) | Method of preparing a preloaded iol injector | |
US20070050023A1 (en) | Preloaded injector for intraocular lenses and methods of making and using | |
WO2001028475A1 (en) | Deformable intraocular lens injecting apparatus and method | |
IL214384A (en) | Automated intraocular lens injector device | |
GB2470416A (en) | Intraocular Lens Cartridge | |
MX2015005713A (en) | Hingeless cartridge for intraocular lens injector providing haptic control. | |
US20040193263A1 (en) | IOL and assembly | |
CN111212613B (en) | Intraocular lens (IOL) injector and method of use | |
AU2020307330A1 (en) | IOL injector plunger having IOL compression arms | |
US20250082463A1 (en) | Preloaded intraocular lens injector and method of use thereof | |
WO2024100002A1 (en) | Intraocular lens injector apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |